- Report
- May 2025
- 182 Pages
Global
From €3131EUR$3,545USD£2,675GBP
€3479EUR$3,939USD£2,972GBP
- Report
- May 2025
- 187 Pages
Global
From €3131EUR$3,545USD£2,675GBP
€3479EUR$3,939USD£2,972GBP
- Report
- May 2025
- 185 Pages
Global
From €3131EUR$3,545USD£2,675GBP
€3479EUR$3,939USD£2,972GBP
- Report
- May 2025
- 175 Pages
Global
From €3966EUR$4,490USD£3,387GBP
- Report
- April 2025
- 200 Pages
Global
From €3966EUR$4,490USD£3,387GBP
- Report
- March 2025
- 175 Pages
Global
From €3966EUR$4,490USD£3,387GBP
- Report
- February 2025
- 200 Pages
Global
From €3966EUR$4,490USD£3,387GBP
- Report
- June 2025
- 368 Pages
Global
From €5167EUR$5,850USD£4,413GBP
- Report
- June 2025
- 179 Pages
Global
From €5167EUR$5,850USD£4,413GBP
- Report
- June 2025
- 183 Pages
Global
From €5167EUR$5,850USD£4,413GBP
- Report
- June 2025
- 400 Pages
Global
From €4371EUR$4,949USD£3,734GBP
- Report
- April 2025
- 200 Pages
Global
From €7021EUR$7,950USD£5,998GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1766EUR$2,000USD£1,509GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1325EUR$1,500USD£1,132GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1325EUR$1,500USD£1,132GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1325EUR$1,500USD£1,132GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3312EUR$3,750USD£2,829GBP
- Report
- December 2023
- 150 Pages
Global
From €5255EUR$5,950USD£4,489GBP
- Report
- January 2024
- 150 Pages
Global
From €2870EUR$3,250USD£2,452GBP
€4284EUR$4,850USD£3,659GBP
- Report
- May 2024
- 131 Pages
Global
From €5740EUR$6,499USD£4,903GBP

Ondansetron is a medication used to treat nausea and vomiting caused by cancer treatments, such as chemotherapy and radiation therapy. It is also used to prevent nausea and vomiting after surgery. Ondansetron is a serotonin 5-HT3 receptor antagonist, which works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting. It is available in both oral and intravenous forms.
Ondansetron is a widely used medication in the gastrointestinal drugs market. It is used to treat nausea and vomiting caused by a variety of conditions, including chemotherapy, radiation therapy, and post-operative nausea and vomiting. It is also used to prevent nausea and vomiting in patients undergoing chemotherapy or radiation therapy.
The market for gastrointestinal drugs is highly competitive, with many companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Novartis. Other companies in the market include AstraZeneca, Takeda Pharmaceuticals, and Daiichi Sankyo. Show Less Read more